ACE2 Overexpression Improves Left Ventricular Remodeling and Function in Rats with Myocardial Infarction
YuXia Zhao,Hui Qiu Yin,Qing Tao Yu,YUN QIAO,Hong Yan Dai,Ming Xiang Zhang,Lei Zhang,Yun Fang Liu,Lai Cheng Wang,De Shan Liu,Bi Ping Deng,Yue Hui Zhang,Chun Ming Pang,Huai Dong Song,Xun Qu,Hong Jiang,Chun Xi Liu,Xiao Ting Lu,Bin Liu,Fei Gao,bo dong
DOI: https://doi.org/10.1089/hum.2009.160
2010-01-01
Human Gene Therapy
Abstract:The purpose of this study was to test the hypothesis that overexpression of angiotensin-converting enzyme 2 (ACE2) may favorably affect left ventricular (LV) remodeling and function after myocardial infarction (MI). The left anterior descending coronary artery was ligated to produce anterior MI in 100 Wistar-Kyoto rats that were randomly divided into Ad-ACE2, Ad-ACE2+A779, Ad-EGFP, model, and sham groups. Two weeks later, rats in the Ad-ACE2 and Ad-EGFP groups received direct intramyocardial injection of Ad-ACE2 and Ad-EGFP, respectively. Rats in the Ad-ACE2+A779 group received both intramyocardial injection of Ad-ACE2 and a continuous intravenous infusion of A779 for 15 days. LV volume and systolic function, the extent of myocardial fibrosis, and levels of ACE2, angiotensin II (Ang II), and collagen I protein expression were evaluated. Four weeks after ACE2 gene transfer, the Ad-ACE2 group showed reduced LV volume, extent of myocardial fibrosis, and expression levels of ACE, Ang II, and collagen I in the myocardium, and increased LV ejection fraction and levels of ACE2 activity and expression in comparison with the Ad-EGFP and model groups. These results suggest that ACE2 overexpression attenuated LV fibrosis and improved LV remodeling and systolic function. In conclusion, overexpression of ACE2 favorably affected the pathological process of LV remodeling after MI by inhibiting ACE activity, reducing AngII levels, and up-regulating Ang-(1-7) expression, thus providing a potential therapeutic target in the treatment of heart failure.